Differential expression and pathological stage analyses revealed that in comparison to the normal pancreas tissue, the expression levels of CD112 and TNFRSF14 were not significantly deregulated in the pancreatic tumors (Figure 1A and B), and did not regularly fluctuate between each of the two different stages (Figure S1A and B). The gene discussed is TNFRSF14; the disease is pancreatic neoplasm.